Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.

Devine, Steven M

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec 2015 - 4167-75 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1527-7755

10.1200/JCO.2015.62.7273 doi


Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Busulfan--administration & dosage
Disease-Free Survival
Drug Administration Schedule
Female
Graft vs Host Disease--diagnosis
Hematopoietic Stem Cell Transplantation
Humans
Immunosuppressive Agents--administration & dosage
Leukemia, Myeloid, Acute--drug therapy
Male
Methotrexate--administration & dosage
Middle Aged
Neoplasm Recurrence, Local--diagnosis
Prospective Studies
Remission Induction
Tacrolimus--administration & dosage
Transplantation Conditioning--methods
Transplantation, Homologous
Treatment Outcome
Unrelated Donors
Vidarabine--administration & dosage